跳至主要内容
临床试验/CTRI/2024/07/071568
CTRI/2024/07/071568尚未招募2 期

A Randomized Open Labelled Controlled Comparative Clinical Study to Evaluate the Efficacy of Matulungadi Avaleha in the Management of Garbhini Chhardi- Emesis Gravidarum - nil

Dr Sakshi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Patients having confirm diagnosis of pregnancy .
  • 2 Patients presenting the classical symptoms of
  • Garbhini chhardi.
  • 3 Patients presenting with symptoms of Emesis
  • Gravidarum.
  • 4 All patient diagnosed with Chhardi during first
  • trimester (both primigravida and multigravida).

排除标准

  • 1 Patients with Hyperemesis Gravidarum.
  • 2 Patients with Hemoglobin less than 8gm%.
  • 3 Vomiting caused due to any medical and surgical condition.
  • 4 Vomiting caused due to systemic disorders like acid peptic ulcer,
  • appendicitis, cholecystitis etc.
  • 5 Patient with PIH (Pregnancy induced hypertension), GDM (Gestational
  • Diabetes Mellitus) and High-risk pregnancies (Molar pregnancy, Ectopic
  • pregnancy).

研究者

发起方
Dr Sakshi

相似试验